Structure

• Excellent researchers and innovators jointly conducting a new quality of interdisciplinary research
• CLARA Testbed - an innovative distributed hybrid computing infrastructure integrated with EuroHPC supercomputers and quantum computers
• Pilot Use Case - Evaluating the Calcium Brain Aging and APOE Cascade hypotheses
• Three research programmes:

1. RP1: Quantum-accelerated supercomputing and machine learning to address protein dynamics, aggregation, and modulation by small molecules.
2. RP2: Expanding systems biology with clinical phenomenology of AD to understand time and scale coupling using generative AI and hybrid computing (HPCQC)
3. RP3: Development of multiscale/cross-modal patient/deep-learning models of AD in the hybrid quantum-classical computing environments

CLARA is an interdisciplinary and distributed center of excellence primarily focused on the application of advanced methods and technologies of artificial intelligence, machine learning, and quantum and supercomputing tools to address the etiology of neurodegenerative diseases. It is operated by six founding partners: INDRC, VSB-TUO, CIIRC CTU, ICRC, PBI, and LRZ.

From a legal and organisational point of view, CLARA is a separate accounting and organisational unit of INDRC, the coordinator of the CLARA project. It has its own CLARA Statute and bodies that shall not be entitled to act or to make legally binding declarations on behalf of any founding partner unless explicitly stated otherwise in the CLARA Grant Agreement or CLARA Consortium Agreement.